The course and outcome of pregnancy was not correlated with the serum HCG value. The mean concentrations in 29 patients admitted once (35-9±2-8 IU/ml) and 13 patients admitted twice or more (33 4+3 1 IU/ml) were similar. Moreover, individual values in patients with subsequent spontaneous abortion (three cases) or preterm delivery (two) were not noticeably different from those in other patients (figure).
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Discussion
Patients with hyperemesis gravidarum had serum HCG concentrations significantly higher than normal between seven and 14 weeks of gestation. Haemoconcentration could be ruled out because packed cell volume and potassium and sodium concentrations in the same samples were within normal limits.
Endocrine and emotional factors are often suggested as important in the aetiology of hyperemesis gravidarum. However, the secretion of adrenocorticotrophic hormone and cortisol"; concentrations of growth hormone, prolactin, and pituitary gonadotrophins ' 2; and progesterone and oestrogens concentrations as reviewed by Fairweather,3 were similar in vomiting and non-vomiting women. Furthermore, attitudes to pregnancy, delivery, marriage, family, children, and spouse showed no difference between healthy and vomiting women. 13 We cannot be certain whether the high concentration of HCG in serum is a primary factor in the aetiology of hyperemesis gravidarum or a secondary change. The association of HCG and hyperemesis gravidarum is supported by the observation that hyperemesis gravidarum begins concomitantly with the rising concentration of HCG; maximum values occur at 10-12 weeks of gestation, when hyperemesis is most common. We postulate that the hypothalamic vomiting centre is sensitive to HCG and that vomiting begins when the individual vomiting threshold concentration of HCG is reached. (Accepted 8 May 1979) Reduction of catheter-associated sepsis in parenteral nutrition using low-dose intravenous heparin M J BAILEY British Medical Journal, 1979 Journal, , 1, 1671 Journal, -1673 Summary and conclusions To assess whether adding low-dose heparin to the infusate of patients receiving parenteral nutrition reduced the incidence of septic complications related to the central venous catheter, 80 consecutive patients requiring intravenous feeding were studied. Half of these patients received heparin 1 unit/ml of infusate, while in the remaining 40 (controls) an equal volume of physiological saline was added to the infusate. Strict criteria for the management of the indwelling CVC were observed. The catheter tips were cultured after removal: only one was infected in the heparin group compared with nine in the control group. This significant reduction may have been due to the heparin preventing a fibrin sleeve from forming around the catheter tip.
It is recommended that, as well as observing the usual
Introduction
The commonest serious complication of parenteral feeding is infection associated with the indwelling central venous cannula,' the reported incidence of infection of the catheter tip varying from 00 to 41 o.2 While this may be minimised by using a careful, aseptic technique when inserting the cannula, regularly inspecting the entry site into the skin, changing the giving set daily, and proscribing the catheter as a route for giving or taking blood or administering drugs, occasional infections will still occur.4 As heparin given via a peripheral venous cannula at a dose of 1 unit/ml of infusate reduces the incidence of thrombophlebitis associated with the cannula, I designed this trial to assess whether a reduction in catheter-associated sepsis could be achieved in patients receiving parenteral nutrition using a similar regimen.
Patients and methods I studied 80 consecutive patients who required intravenous feeding. The only criterion for entry into the trial was that I inserted or supervised the insertion of the central venous catheter. The catheter was inserted with full sterile precautions, the operator wearing a mask and sterile gloves. The skin was prepared with povidone-iodine solution, and the catheter when inserted was securely sutured to the skin to prevent movement at the entry site. The area of entry was then sprayed with povidone-iodine aerosol, covered with a sterile gauze dressing, and occluded with Sleek. The right subclavian route was used routinely to insert the catheter, and the position of the catheter tip was checked radiologically. The puncture site was examined on alternate days after insertion, unless a fever prompted earlier inspection. If the site was uninflamed the area was sprayed with povidone iodine and redressed; if it was inflamed (more than minimal local erythema) the catheter was removed as described below. The regimen for intravenous feeding was determined by the team in charge of the patient, but the following criteria were observed in all cases: (1) The central venous catheter was used solely to administer sterile intravenous fluids. Blood and blood fractions were given when necessary via a separate peripheral cannula. (2) Blood samples were not withdrawn from the catheter. (3) Drugs were not administered via the catheter, nor were any drugs added to the infusate after it left the pharmacy. (4) The giving set was changed daily.
Patients were randomly allocated into two groups on entering the trial. To each 500 ml of intravenous fluid was added 500 units of heparin for patients in the treatment group and 0 5 ml of physiological saline for patients in the control group, all additions being made under sterile conditions in the pharmacy. Only the pharmacy knew to which group each patient belonged.
Each central venous catheter was removed as follows. The dressing covering the puncture site was removed and a swab taken for culture where the catheter entered the skin. The whole area was then prepared with povidone-iodine solution, which was allowed to dry. The operator, wearing a mask and sterile gloves, removed the catheter and cut off the terminal 1 cm with sterile scissors, allowing the tip to fall into transport medium, which was then sent to the microbiology laboratory for culture. Indications for removal of the catheter were: (1) completion of treatment ("elective"); (2) appreciable inflammation around the puncture site; (3) pyrexia of over 37°C for more than 12 hours not accounted for by sepsis unrelated to the catheter (for example, chest or wound infection); (4) positive blood culture; and (5) mechanical failure. In all patients with temperature of 37°C or above at least three blood cultures were taken. Antibiotics were prescribed when clinically indicated, and patients who received antibiotics were not excluded from the trial. Catheters were not changed routinely unless one of the five conditions above was fulfilled.
Results
In 10 patients positive cultures were obtained from the catheter tip; one of these patients was in the treatment group and the remaining nine in the control group. Three of these nine control patients also had positive blood cultures, the same organism being isolated from the blood and the catheter. Table I shows the organisms isolated. The difference in the incidence of infection of the catheter tips in the two groups was significant (X2 = 73; P <001) but the difference in the numbers of positive blood cultures associated with infection of the The series reported here shows an appreciable reduction in the incidence of catheter-tip infection after the addition of heparin at a dose of one unit per ml of infusate in patients receiving parenteral nutrition through a central venous catheter. None of the patients in the treatment group had positive blood cultures, but in three controls the same organism was isolated from the catheter tip and from blood sampled just before the catheter was removed. Only one catheter tip in the treatment group compared with nine in the control group was infected.
The lowest rates of catheter-associated sepsis are reported from units in which a team is specifically designated to manage the care of the catheter and other aspects of intravenous nutri- 
Case report
In may 1977 a 15-year-old schoolgirl attended the medical outpatient clinic complaining of pain behind the sternum on swallowing. This had started suddenly about one month previously and had been very severe at first, so that even eating jelly had brought tears to her eyes. There had then been an improvement, but some pain still persisted. After the onset of symptoms she had been treated for one week with tetracycline but denied taking any other medications. At the age of 5 she had been investigated for mild unsteadiness on walking and early morning incontinence, but no neurological diagnosis had been reached and no treatment advised. There were no abnormal physical signs.
Investigations showed haemoglobin 13 6 g/dl, white cell count 6 x 109/1, and ESR 15 mm in one hour. Chest radiograph was normal. Barium swallow showed no abnormality. In view of her symptoms rigid endoscopy was performed on 12 July under general anaesthesia. Severe circumferential mucosal ulceration was present with slough formation between 23 and 27 cm from the incisor teeth. The oesophagoscope could be passed through the area, and the distal oesophageal mucosa was found to be squamous and normal. Biopsy specimens from the ulcerated area showed non-specific acute and chronic inflammatory infiltrate with basal cell hyperplasia. In view of this unusual pathological appearance in the mid-oesophagus, she was questioned more carefully about drugs. It On 27 July, while taking the drug treatment, the patient was screened radiologically after swallowing a tablet of emepronium bromide (200 mg) that had been rendered radio-opaque by drilling the surface and filling the hole with barium sulphate. This was swallowed dry, as was her normal practice, and was seen to pass to the level of the aortic arch, where it became impacted (fig 1) . Twenty minutes later the tablet was still at the same level, and it did not move until liquid barium was administered. Later, oesophageal mannometry studies were undertaken with the patient off the drug and then again two days~~~~~~~~F IG 1 Tablet of emepronium bromide impacted in oesophagus just above aortic arch. 
